Life From Vision in Alzheimer Disease (VIVA)
|ClinicalTrials.gov Identifier: NCT00838942|
Recruitment Status : Completed
First Posted : February 9, 2009
Last Update Posted : October 28, 2011
|Condition or disease||Intervention/treatment|
|Alzheimer Disease Cataract||Behavioral: Questionaries|
Show Detailed Description
|Study Type :||Observational|
|Actual Enrollment :||80 participants|
|Official Title:||Cataract Surgery Benefice in Improvement of Behaviour, Autonomy and Mood for Alzheimer Patients.|
|Study Start Date :||December 2004|
|Actual Primary Completion Date :||March 2011|
|Actual Study Completion Date :||April 2011|
Patients suffering from both Alzheimer's disease and low vision due to a bilateral impeding cataract.
MMS (Mini Mental Status), ADAS-cog Alzheimer Disease Assessment Scale for cognitive functions, NPI (Neuropsychiatric Inventory) for behavior troubles, IADL (Instrumental Activities of Daily) for autonomy evaluation, GDS (Geriatric Depression Scale) or Cornell Scale (Cornell Scale for Depression in Dementia) for mood troubles.
- Improvement score of the NPI (Neuropsychiatric Inventory). The improvement is based on the increase by 1 point on the score of NPI [ Time Frame: 3 month after cataract surgery ]
- Improvement score of MMS(Mini mental status), of ADAS-COG(Alzheimer disease Assessment scale for cognitive function), IADL(Instrumental activity on daily) and GDS(Geriatric depression scale). [ Time Frame: 3 month after cataract surgery ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00838942
|Hopital Tenon, Service Ophtalmologie|
|Paris, France, 75020|
|Principal Investigator:||Brigitte GIRARD, MD PhD||Assistance Publique - Hôpitaux de Paris|